Breast cancer cases in the advanced stage of disease had 16.78-fold NRXN-1 mRNA expression while early-stage breast cancer patients showed 3.18-fold NRXN-1 mRNA expression and differences between them were found to be statistically significant (p < 0.0001). This evidence concerns the gene NRXN1 and breast carcinoma.